Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H13N3O3S |
Molecular Weight | 267.304 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1
InChI
InChIKey=CYFLXLSBHQBMFT-UHFFFAOYSA-N
InChI=1S/C11H13N3O3S/c1-7-8(2)17-11(13-7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6H,12H2,1-2H3,(H,13,14)
Molecular Formula | C11H13N3O3S |
Molecular Weight | 267.304 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Sources: http://www.google.com.tr/patents/US2809966
Curator's Comment: reference retrieved from http://www.druglead.com/cds/Sulfamoxole.html
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2364668 Sources: https://www.drugbank.ca/drugs/DB08798 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Sulfuno Approved UseSulfuno (500mg) (Sulfamoxole) is a sulfonamide antibacterial, prescribed for susceptible infections. |
PubMed
Title | Date | PubMed |
---|---|---|
Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole. | 1988 Dec |
|
Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. | 1995 Aug |
|
Determination of some sulfonamides and trimethoprim in chicken, fish muscle and eggs by liquid chromatography-tandem mass spectrometry. | 2004 Apr-Jun |
|
Multiwalled carbon nanotubes as sorbent for on-line coupling of solid-phase extraction to high-performance liquid chromatography for simultaneous determination of 10 sulfonamides in eggs and pork. | 2006 Sep 15 |
|
Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach. | 2009 Mar |
Patents
Sample Use Guides
Adults Dose:
Initially 1g to be taken twice daily followed by 500 mg two times a day
Child Dose:
Initial dose is 50 to 60 mg/kg daily
Maximum daily dose is 75mg daily
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15061593
sulfamoxole was taken in different doses (500, 1000, 1500, 2000 and 2500 ppm) to test their effectiveness against five pathogenic fungi for the control of mycelial growth and sporulation.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:53 GMT 2023
by
admin
on
Fri Dec 15 15:13:53 GMT 2023
|
Record UNII |
HGG82XE020
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
J01EE04
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
||
|
WHO-ATC |
J01EC03
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
211-982-7
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
10183
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | RxNorm | ||
|
HGG82XE020
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
729-99-7
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
DB08798
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
m10326
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | Merck Index | ||
|
C152456
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
DTXSID5023617
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
SULFAMOXOLE
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
SUB10717MIG
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105399
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
55548
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
683535
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
12894
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
100000083293
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
55546
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
2520
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
1277
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY | |||
|
D013423
Created by
admin on Fri Dec 15 15:13:53 GMT 2023 , Edited by admin on Fri Dec 15 15:13:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |